Get started
Author

Mariana Michelle Ramírez-Mejía

Observed names: M.M. Ramírez-Mejía, Mariana M Ramírez-Mejía, Mariana M. Ramírez-Mejia, Mariana M. Ramírez-Mejía, Mariana M. Ramírez‐Mejía, Mariana Ramirez-Mejia, Mariana Ramírez-Mejía, Ramírez-Mejía Mariana M.
ORCID: 0009-0005-6279-1527
Observed ORCID: 0009-0005-6279-1527
OpenAlex ID: A5091020767
Breaking new ground: MASLD vs. MAFLD—which holds the key for risk stratification?
2023 · Mariana Michelle Ramírez-Mejía, Carlos Jiménez-Gutiérrez, et al. · Hepatology International · 91
The Multifaceted Role of Bilirubin in Liver Disease: A Literature Review
2024 · Mariana M. Ramírez-Mejía, Stephany M. Castillo-Castañeda, et al. · Journal of Clinical and Translational Hepatology · 56
PDF
From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function
2024 · David Medina-Julio, Mariana M. Ramírez-Mejía, et al. · Medical Science Monitor · 44
Metabolic dysfunction: The silenced connection with fatty liver disease
2023 · Mariana M. Ramírez-Mejía, Xingshun Qi, et al. · Annals of Hepatology · 43
GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications
2025 · Mariana M. Ramírez-Mejía, Guadalupe Ponciano-Rodriguez, et al. · Therapeutic Advances in Endocrinology and Metabolism · 35
A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health
2021 · Mariana M. Ramírez-Mejía, Luis E. Díaz-Orozco, et al. · Medical Science Monitor · 32
What Is in a Name: from NAFLD to MAFLD and MASLD—Unraveling the Complexities and Implications
2023 · Mariana M. Ramírez-Mejía, Nahum Méndez-Sánchez · Current Hepatology Reports · 20
Implications of the Liver-Gut Axis in Liver Disease: From Mechanisms to Therapeutic Targets
2025 · Mariana M. Ramírez-Mejía, Guadalupe Ponciano-Rodríguez, et al. · Archives of Medical Research · 15
Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals
2024 · Nahum Méndez-Sánchez, Carlos E. Coronel-Castillo, et al. · Pathogens · 14
PDF
Bilirubin Molecular Species Play an Important Role in the Pathophysiology of Acute-on-Chronic Liver Failure
2024 · Stephany M. Castillo-Castañeda, Jacqueline Cordova-Gallardo, et al. · International Journal of Molecular Sciences · 10
PDF
The Mechanisms behind Thrombocytopenia in Patients with Portal Hypertension and Chronic Liver Disease
2025 · Valeria M. Fernández-Garibay, Mariana M. Ramírez-Mejia, et al. · Journal of Clinical and Translational Hepatology · 9
PDF
The myth of the stigma of fatty liver: What does the evidence show?
2024 · Mariana M. Ramírez-Mejía, Xingshun Qi, et al. · Annals of Hepatology · 9
Organokine-Mediated Crosstalk: A Systems Biology Perspective on the Pathogenesis of MASLD—A Narrative Review
2025 · Sandra Maria Barbalho, Lucas Fornari Laurindo, et al. · International Journal of Molecular Sciences · 7
PDF
The MAFLD and MASLD conundrum: Is it reinvention of the wheel?
2024 · Mariana M. Ramírez-Mejía, Mohammed Eslam, et al. · Journal of Hepatology · 7
PDF
From prediction to prevention: Machine learning revolutionizes hepatocellular carcinoma recurrence monitoring
2024 · Mariana Michelle Ramírez-Mejía, Nahum Méndez-Sánchez · World Journal of Gastroenterology · 7
PDF
Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study
2023 · Shreya C. Pal, Stephany M. Castillo-Castañeda, et al. · Genes · 6
PDF
NAFLD-MASLD-MAFLD continuum: A swinging pendulum?
2024 · Mariana M. Ramírez-Mejía, Xingshun Qi, et al. · Annals of Hepatology · 5
How the gut-liver axis shapes hepatic encephalopathy: mechanistic and therapeutic perspectives
2025 · Arnulfo E. Morales-Galicia, Mariana N. Rincón-Sánchez, et al. · Exploration of Digestive Diseases · 4
PDF
Epidemiology and etiologic trends of hepatocellular carcinoma in cirrhotic patients in Mexico: a multicenter retrospective study (2018–2024)
2025 · Nahum Méndez-Sánchez, Mariana M. Ramírez-Mejía, et al. · Annals of Hepatology · 4
Changing Landscape of Liver Cirrhosis Etiologies
2025 · Nahum Méndez-Sánchez, Mariana M Ramírez-Mejía, et al. · Archives of Medical Research · 4
The interplay of insulin resistance, glycemic variability, and metabolic dysfunction-associated steatotic liver disease
2026 · Fernanda M. Martínez-Díaz, Elsie A. Jiménez-Cuevas, et al. · Exploration of Digestive Diseases · 3
Outcome prediction for cholangiocarcinoma prognosis: Embracing the machine learning era
2025 · Arnulfo E Morales-Galicia, Mariana N Rincón-Sánchez, et al. · World Journal of Gastroenterology · 3
PDF
Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury
2025 · Mariana M Ramírez-Mejía, Rolf Teschke, et al. · World Journal of Hepatology · 3
Duodenal mucosal ablation by irreversible electroporation: Modulating the gut-liver axis in metabolic steatotic liver disease
2025 · Mariana M Ramírez-Mejía, Nahum Méndez-Sánchez · World Journal of Hepatology · 2
PDF
Non-invasive biomarkers for monitoring portal hypertension in metabolic dysfunction-associated steatotic liver disease (MASLD)
2025 · Shreya C. Pal, Mariana M. Ramírez-Mejía, et al. · Expert Review of Gastroenterology & Hepatology · 2
Works count: 57
Citation count: 443
H-index: 10
I10-index: 10
Year
Topic
Type